Maxwell Biosciences Email Formats

Biotechnology Research • Austin, Texas, United States • 21-50 Employees

Maxwell Biosciences Email Formats

Maxwell Biosciences uses 2 email formats. The most common is {first initial} (e.g., j@maxwellbiosciences.com), used 50% of the time.

Format	Example	Percentage
{first initial}	j@maxwellbiosciences.com	50%
{first name}	john@maxwellbiosciences.com	50%

Key Contacts at Maxwell Biosciences

Sheetal Vali

Sr. Director Of Drug Development

Sarah Aubrey

Director Of Planning

Jon Mcclure

Chief Technology Officer

Meagan Stone

Sr. Director Of Operations

Michaela Johnson

Associate Director Of Research Administration

Company overview

Headquarters	Austin, Texas, United States
Phone number	+18556292461
Website	maxwellbiosciences.com
NAICS	541714
SIC	873
Founded	2016
Employees	21-50
Socials

About Maxwell Biosciences

Next Generation Anti-Infectives that Mimic Natural Human Antimicrobial Peptides Maxwell Biosciences is a preclinical stage drug platform company partnering with large pharma companies to develop an entirely new class of patented low molecular weight drug candidates that destroy SARS-CoV-2, the COVID virus, as well as other viruses and infectious pathogens (including fungal and bacterial pathogens). Maxwell's first-in-class CLAROMER™ brand drug discovery platform mimics natural human immune system antimicrobial and antiviral peptides. Maxwell Biosciences has benefitted from over $35M of non-dilutive grants and awards from governments around the world to validate their science and technology, including studies by US Govt-funded labs confirming that Maxwell's lead drug candidate has direct virucidal action against Herpes virus (HSV-1) and SARS-CoV-2, the COVID virus. Additionally, live mouse safety data at Texas A&M show Maxwell's drugs benefit from a tissue-safe toxicology profiles, and live mouse studies from the Baylor College of Medicine show breakthrough fungicidal action with CLAROMER™ brand compounds against lethal fungal infections of the upper-respiratory tract. These findings support the expected safety and effectiveness of Maxwell's “multi-asset, multi-target” anti-infectives drug platform. Maxwell's drug platform is supported by a granted patent portfolio and is strongly positioned in the fight against emergent viral pandemics and a broad spectrum of evolving infectious pathogens. Maxwell is raising funds for advanced preclinical and human trials.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

C-Suite

Senior

Director

Employees by Department

Maxwell Biosciences has 8 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Maxwell Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2022-04-10	3	$10,800,000
2023-02-01	1	N/A
2025-09-05	15	$20,000,000

Funding Insights

$30,800,000

Total funding amount

$20,000,000

Most recent funding amount

Number of funding rounds

Maxwell Biosciences Tech Stack

Discover the technologies and tools that power Maxwell Biosciences's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

reCAPTCHA

Security

Cloudflare

CDN

Stimulus

JavaScript frameworks

HSTS

Security

Google Analytics

Analytics

Google Workspace

Adobe Fonts

Font scripts

Emotion

Development

Squarespace Commerce

Ecommerce

Google Tag Manager

Tag managers

core-js

JavaScript libraries

Frequently asked questions

Maxwell Biosciences is located in Austin, Texas, US.

You can reach Maxwell Biosciences at +18556292461.

Maxwell Biosciences was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Maxwell Biosciences has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Maxwell Biosciences has raised a total of $30,800,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.